Vasomedical, Inc. - EECP® Therapy

What's New

Vasomedical Applauds the International EECP® Therapist Association Call for International EECP® Therapy Week in Recognition of American Heart Month

Chapter Dedicated to EECP® Therapy in New Textbook on Coronary Artery Disease

Vasomedical Recorded Record Net Income of $2.47 Million for the Second Quarter of Fiscal 2012

Vasomedical and EECP® Therapy Presented on at the OneMedForum2012 in San Francisco

More >>

EECP Newsletter

VasoHealthcare Sales Professionals

VasoHealthcare, a wholly owned subsidiary of Vasomedical, Inc., represents GE Healthcare, the healthcare business unit of GE, for the sale of select GE Healthcare Diagnostic Imaging products. VasoHealthcare's team of over 70 highly qualified and experienced sales professionals and world class support personnel are led by a visionary management group that specializes in high-tech medical equipment sales to specific market segments in the 48 contiguous states of the United States and District of Columbia.

EECP® Therapy

Offered exclusively by Vasomedical, Inc. EECP® therapy is a safe, non-invasive, outpatient treatment option for patients suffering from ischemic heart diseases such as angina and heart failure. EECP® therapy has helped thousands of patients. In fact, clinical studies show, over 75% of patients benefit from EECP® therapy and sustain improvement up to three years post- treatment.

Watch heart failure and angina patients and cardiologists describe the benefits of noninvasive, outpatient EECP® Therapy.

Play Videos >

Holter Monitoring Products

Vasomedical-BIOX Model1305, 3-Channel ECG Holter Recorder	CB Series Analysis Software

Learn More >	Learn More >

Locate Treatment